Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an Amendment No. 12 to its Schedule 13G, disclosing a 9.0% beneficial ownership stake in Pentair plc as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 6.9% of Medtronic plc's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 10 to Schedule 13G, reporting a 6.7% beneficial ownership stake in Johnson Controls International PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 8.7% Stake in WPP PLC
BlackRock, Inc. has filed an updated Schedule 13G, disclosing its continued beneficial ownership of 8.7% of WPP PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a 7.2% beneficial ownership stake in Amcor PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.3% Passive Stake in NovoCure Ltd
Investment giant BlackRock, Inc. has reported a passive beneficial ownership of 8.3% in NovoCure Ltd's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.2% Passive Stake in Nomura Holdings Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.2% beneficial ownership stake in Nomura Holdings Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Updates Significant Passive Stake in Ambarella, Holding 7.3% of Common Stock
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, disclosing a 7.3% beneficial ownership stake in Ambarella, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing its beneficial ownership of 7.3% of the common stock of FTAI Aviation Ltd. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing an increased beneficial ownership of 7.1% in Rio Tinto PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed Amendment No. 4 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in BP PLC as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, reporting a beneficial ownership of 7.3% of Smith & Nephew PLC's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.6% Passive Stake in AstraZeneca PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% beneficial ownership stake in AstraZeneca PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.2% Passive Stake in TE Connectivity PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.2% passive beneficial ownership stake in TE Connectivity PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.1% Stake in Adient plc, Maintaining Significant Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.1% beneficial ownership stake in Adient plc as of March 31, 2025, through various subsidiaries and managed funds.
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Willis Towers Watson, Holding 7.6% of Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.6% passive ownership stake in Willis Towers Watson PLC as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to Schedule 13G, reporting a 9.0% beneficial ownership stake in nVent Electric plc as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in Allegion Public Limited Company, Discloses 7.5% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.5% beneficial ownership stake in Allegion Public Limited Company as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.7% Passive Stake in Trane Technologies plc
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.7% beneficial ownership stake in Trane Technologies plc as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.5% Stake in National Grid PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.5% of National Grid PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.3% beneficial ownership stake in consumer health company Haleon PLC as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing its beneficial ownership of 11.1% of Luxfer Holdings PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% beneficial ownership stake in Shell plc's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.0% beneficial ownership stake in Diversified Energy Co PLC as of March 31, 2025, held for investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Kiniksa Pharmaceuticals, Reports 5.4% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 5.4% beneficial ownership stake in Kiniksa Pharmaceuticals International, plc as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.2% Stake in AngloGold Ashanti PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.2% beneficial ownership stake in AngloGold Ashanti PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.5% Stake in British American Tobacco PLC
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.5% of British American Tobacco PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 8.2% of Pearson PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.8% passive beneficial ownership stake in Prudential Public Limited Company as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a 5.3% beneficial ownership stake in Lions Gate Entertainment Corp's Class A Stock as of March 31, 2025.